A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex Formation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  D'Agostino, Vito G ^a   Adami, Valentina ^a   Provenzani, Alessandro ^a  

^a UNIVERSITY OF TRENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ASPARTAME; CEFRADINE; CETYLPYRIDINIUM SALT; CLOMIFENE CITRATE; CRYSTAL VIOLET; DILOXANIDE FUROATE; HUR PROTEIN; HYDROQUINONE; MITOXANTRONE; NONOXINOL 9; PROTOVERATRINE; RALOXIFENE; SALSALATE; SINGLE STRANDED RNA; SWITENOLIDE DIACETATE; TETRAHYDROLIPSTATIN; TETRANDRINE; TILMICOSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING KINETICS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EMBRYO; GEL MOBILITY SHIFT ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN RNA BINDING;

AU RICH ELEMENTS; BINDING, COMPETITIVE; CELL LINE; HIGH-THROUGHPUT SCREENING ASSAYS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; KINETICS; OLIGORIBONUCLEOTIDES; PROTEIN BINDING; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; RNA, MESSENGER; TRISTETRAPROLIN;

EID: 84881501527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072426     Document Type: Article

References (34)

1. Burd CG, Dreyfuss G, (1994) RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 5: 1197-1204. PubMed: 7510636.
2. Chen CY, Shyu AB, (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 11: 465-470. PubMed: 8578590.
3. Fan XC, Steitz JA, (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci U S A 26: 15293-15298.
4. Dassi E, Zuccotti P, Leo S, Provenzani A, Assfalg M, et al. (2013) Hyper conserved elements in vertebrate mRNA 3'-UTRs reveal a translational network of RNA-binding proteins controlled by HuR. Nucleic Acids Res 5: 3201-3216. PubMed: 23376935.
5. Park S, Myszka DG, Yu M, Littler SJ, Laird-Offringa IA, (2000) HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol Cell Biol 13: 4765-4772.
6. Wang H, Li H, Shi H, Liu Y, Liu H, et al. (2011) Preliminary crystallographic analysis of the RNA-binding domain of HuR and its poly(U)-binding properties. Acta Crystallogr Sect Struct Biol Cryst Commun 5: 546-550. PubMed: 21543858.
7. Eberhardt W, Doller A, Akool el S, Pfeilschifter J, (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 1: 56-73. PubMed: 17320967.
8. Latorre E, Tebaldi T, Viero G, Spartà AM, Quattrone A, et al. (2012) Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. Mol Cancer 11: 13. doi:10.1186/1476-4598-11-13. PubMed: 22436134.
9. Srikantan S, Gorospe M, (2012) HuR function in disease. Front Biosci 17: 189-205. doi:10.2741/3921. PubMed: 22201738.
10. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, et al. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 3: 760-769. PubMed: 10629032.
11. Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M, (2008) Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 3: 243-255. PubMed: 18177264.
12. Sakai K, Kitagawa Y, Hirose G, (1999) Binding of neuronal ELAV-like proteins to the uridine-rich sequence in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. FEBS Lett 1: 157-162. PubMed: 10100634.
13. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, et al. (2006) IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 12: 2112-2114. PubMed: 16935932.
14. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G, (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 3: 387-398. PubMed: 10204494.
15. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, et al. (2001) The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 3: 721-730. PubMed: 11154260.
16. Tiedje C, Ronkina N, Tehrani M, Dhamija S, Laass K, et al. (2012) The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLOS Genet 9: e1002977. PubMed: 23028373.
17. Eglen RM, Reisine T, Roby P, Rouleau N, Illy C, et al. (2008) The use of AlphaScreen technology in HTS: current status. Curr Chem Genomics 1: 2-10. doi:10.2174/1875397300801010002. PubMed: 20161822.
18. Zhang JH, Chung TD, Oldenburg KR, (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 2: 67-73.
19. Kim YU, Rus HG, Fisher SN, Pitha PM, Shin ML, (1996) Binding of a protein to an AU-rich domain of tumour necrosis factor alpha mRNA as a 35 kDa complex and its regulation in primary rat astrocytes. Biochem J 2: 455-460.
20. Meisner NC, Hackermüller J, Uhl V, Aszódi A, Jaritz M, et al. (2004) mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure. Chembiochem 10: 1432-1447. PubMed: 15457527.
21. Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, et al. (2007) Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J Biol Chem 29: 20948-20959. PubMed: 17517897.
22. Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, et al. (2006) Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun 1: 160-168. PubMed: 16759646.
23. Basu A, Datta D, Zurakowski D, Pal S, (2010) Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development. J Biol Chem 285: 25196-25202. doi:10.1074/jbc.M110.119446. PubMed: 20554520.
24. Viiri J, Amadio M, Marchesi N, Hyttinen JMT, Kivinen N, et al. (2013) Autophagy activation clears ELAV1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLOS ONE. doi:10.1371/journal.pone.0069563.
25. Chae MJ, Sung HY, Kim EH, Lee M, Kwak H, et al. (2009) Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA. Exp Mol Med 11: 824-831. PubMed: 19949288.
26. Meisner NC, Hintersteiner M, Mueller K, Bauer R, Seifert JM, et al. 2207) Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol 8: 508-515.
27. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP, (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2: 244-279. PubMed: 18155297.
28. Brennan CM, Steitz JA, (2001) HuR and mRNA stability. Cell Mol Life Sci 2: 266-277. PubMed: 11289308.
29. Ross J, (1996) Control of messenger RNA stability in higher eukaryotes. Trends Genet 5: 171-175. PubMed: 8984731.
30. Alberts DS, Griffith KS, Goodman GE, Herman TS, Murray E, (1980) Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug. Cancer Chemother Pharmacol 5(1):: 11-15. doi:10.1007/BF00578556. PubMed: 7460190.
31. Kapuscinski J, Darzynkiewicz Z, Traganos F, Melamed MR, (1981) Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids. Biochem Pharmacol 30(3):: 231-240. doi:10.1016/0006-2952(81)90083-6. PubMed: 7225141.
32. Edan G, Morrissey S, Le Page E, (2004) Rationale for the use of mitoxantrone in multiple sclerosis. J Neurol Sci, 223(1):: 35-39. doi:10.1016/j.jns.2004.04.017. PubMed: 15261558.
33. Kapuscinski J, Darzynkiewicz Z, (1986) Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids. Proc Natl Acad Sci U S A 83(17):: 6302-6306. doi:10.1073/pnas.83.17.6302. PubMed: 3462696.
34. Zheng S, Chen Y, Donahue CP, Wolfe MS, Varani G, (2009) Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Chem Biol. 16(5):557-66.